Risk Management in Type 2 Diabetes Population
Medication Review to Prevent Drug Therapy Problems By: Cynthia Nwaubani, PharmD and Tessa Culhane Type 2 diabetes is the most common type of diabetes in the world. As many as 34 million Americans have diabetes, and 90-95% have type 2 diabetes.1 With the growing number of people being diagnosed with type 2 diabetes, everyday health […]
Medication Risk Management in Diabetes
By Matthew Gehrlein, PharmD Candidate and PharmD Live Student Intern What is Medication Risk Management? All medications have risks and benefits. The FDA, physicians, providers, and pharmacists all work to ensure that the balance of risks and benefits is favorable to each patient when they take their medication. The practice of assessing risks versus benefits […]
Tirzepatide: a new glucagon-like peptide for patients with diabetes II
By: Hannah Grice, PharmD In the United States, 34.2 million people have diabetes,1 the majority of them have type II diabetes. Type II diabetes is a chronic disease characterized by elevated blood glucose. Management of type II diabetes is multifactorial: diet, exercise, and pharmacotherapy are all part of the treatment. Recently, a new medication called […]